Integral Health Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Integral Health Asset Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-250,000	Closed	-$2.85M	–	89
2021 Q3	$2.85M	Sell	250,000 -160,000	-39%	-$2.34M	0.82%	47
2021 Q2	$6.56M	Buy	410,000 +60,000	+17%	+$1.03M	1.81%	21
2021 Q1	$6.25M	Buy	350,000 +150,000	+75%	+$2.59M	1.79%	19
2020 Q4	$2.7M	Buy	+200,000	New	+$2.42M	0.8%	40

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Integral Health Asset Management's AERI Position: Q4 2021 in Review

Integral Health Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 250,000 shares — an estimated $2.85M sold.

Integral Health Asset Management first reported a position in AERI in Q4 2020 and held it in 4 quarters. The position peaked at $6.56M in Q2 2021. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

Integral Health Asset Management reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Integral Health Asset Management sold 250,000 Aerie Pharmaceuticals shares in Q4 2021, an estimated $2.85M.
Integral Health Asset Management first reported a position in Aerie Pharmaceuticals in Q4 2020 and held it in 4 quarters.
Integral Health Asset Management's Aerie Pharmaceuticals position peaked at $6.56M in Q2 2021.
129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on Integral Health Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.